Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy?
Oral Oncol. 2020 Jul:106:104803.
doi: 10.1016/j.oraloncology.2020.104803.
Epub 2020 May 14.
1 National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
2 National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy. Electronic address: barbara.vischioni@cnao.it.
3 Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
4 Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
5 Section of Otorhinolaryngology - Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy.
6 Department of Otorhinolaryngology, Maxillofacial and Thyroid Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Oncohaematology, University of Milan, Milan, Italy.
7 Division of Otolaryngology and Head-Neck Surgery, IEO, European Institute of Oncology IRCCS, Milano, Italy.
8 Department of Otorhinolaryngology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.